M. Schäfer-Korting

Evaluation of Therapeutic Benefits and Toxicological Risks Using Structure-Activity Relational Expert Systems

Hans C. Korting, M. Schäfer-Korting, 1998 .

Pharmacokinetics of nadolol in healthy subjects

M. Schäfer-Korting, N. Bach, H. Knauf, 2004, European Journal of Clinical Pharmacology.

Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris

M. Schäfer-Korting, O. Braun-falco, M. Schäfer-Korting, 2004, European Journal of Clinical Pharmacology.

Comparative Study of Carotenoids, Catalase and Radical Formation in Human and Animal Skin

M. Schäfer-Korting, W. Sterry, J. Lademann, 2010, Skin Pharmacology and Physiology.

The Phenion® Full-Thickness Skin Model for Percutaneous Absorption Testing

M. Schäfer-Korting, M. Schäfer-Korting, K. Ackermann, 2009, Skin Pharmacology and Physiology.